Biomerica (BMRA) Revenue (2010 - 2026)

Biomerica has disclosed Revenue across 17 years of filings, most recently posting $987000.0 for Q1 2026.

• Revenue for Q1 2026 came in at $987000.0, down 11.8% year-over-year; the trailing twelve-month figure through Feb 2026 was $4.3 million (down 23.81% YoY), and the FY2025 annual result was $5.3 million, down 1.92% from the prior year.
• Revenue came in at $987000.0 for Q1 2026 at Biomerica, down from $1.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.7 million in Q1 2022 to a low of $749000.0 in Q2 2025.
• The 5-year median for Revenue is $1.4 million (2025), against an average of $1.9 million.
• Across the five-year window, Revenue jumped 403.02% in 2022 and plunged 85.5% in 2023, its largest moves.
• Biomerica's Revenue stood at $1.5 million in 2022, then increased by 5.74% to $1.6 million in 2023, then gained by 4.4% to $1.6 million in 2024, then dropped by 26.04% to $1.2 million in 2025, then dropped by 18.43% to $987000.0 in 2026.
• The last three Revenue figures came in at $987000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.